FDA Approved: SOMA — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Soma (carisoprodol) submitted by Viatris Specialty LLC, updating the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Musculoskeletal Pain

Drugs mentioned

• SOMA (carisoprodol)

Snippet

SUPPL AP for SOMA (CARISOPRODOL)